Fact Source: Financial Supervisory Service DART
💡 3-Second Summary
Samsung Biologics has announced that it plans to release its annual earnings results for FY2025 on January 21, 2026.
📊 [Key Disclosure Details & Financial Figures]
- Company Name: SAMSUNG BIOLOGICS CO.,LTD.
- Fiscal Period: January 1, 2025 – December 31, 2025 (FY2025)
- Scheduled Disclosure Date: January 21, 2026
- Other Important Investment Details:
- Earnings materials will be posted on the corporate website (https://www.samsungbiologics.com) after fair disclosure.
- The scheduled disclosure date is subject to change depending on company circumstances.
📝 Editor’s Comment (Key Follow-up Checkpoint)
📌 Verifying the Execution and Official Content of the Scheduled FY2025 Earnings Release on January 21, 2026
This disclosure serves as a schedule notification providing advance notice of the publication date for FY2025 earnings results.
Checking whether the disclosure is published as scheduled on January 21, 2026, is crucial for tracking the release status and official details of the FY2025 financial results.
Relevant details can be verified in the subsequent earnings disclosure scheduled for January 21, 2026, and company IR materials.
📢 Disclaimer & Source Notice
Source: This content was structured and regenerated based on official data submitted to the Financial Supervisory Service’s DART system.
Investment Risk Warning: This content is provided solely for informational and educational purposes. Under no circumstances does it constitute financial advice or a recommendation to buy or sell any security. All investment decisions and financial responsibilities rest entirely with the investor.
Contact: For compliance inquiries or copyright requests, please contact ksb220805@gmail.com.
